(5-Chlorobenzo[d][1,3]dioxol-4-yl)boronic acid, 98%, 100mg

4-(2-Fluoro-4-nitrophenyl)morpholine, 97.0%, 500g

(2E,4E)-Hepta-2,4-dienal, 90.0%, 25g

(R)-tert-Butyl (1-hydrazinyl-1-oxopropan-2-yl)carbamate, 1g

1-(5,6-Dichloropyridin-3-yl)ethanone, 95.0%, 5g

1-(Phenylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine, 98%, 100mg

5-(2-Iodophenyl)-3-methyl-1,2,4-oxadiazole, 95%, 100mg

4-Fluorobenzyl mercaptan, 98.0%, 5g

3-(2-Fluoro-phenyl)-3-oxo-propionic acid methylester, 96.0%, 25g

7-Bromo-2-methyloxazolo[4,5-c]pyridine, 95.0%, 5g

GC capillary column ROTI®Cap-35 MS, 60 m, 0.32 mm, 1 Piece(s)

(R)-2-((4-Aminophenethyl)amino)-1-phenylethanol, 95.0%, 5g

6-(Dimethylamino)picolinaldehyde, 95.0%, 250mg